Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Alzheimer’s disease (AD), as a neurodegenerative disorder, usually develops slowly but gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is recognized by WHO as a public health priority. Being a multifactorial disease, the origins of AD are not satisfactorily unde...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Revisão |
| 言語: | 英語 |
| 出版事項: |
2023
|
| オンライン･アクセス: | https://doi.org/10.3390/pharmaceutics15030916 https://www.mdpi.com/1999-4923/15/3/916/pdf?version=1678689773 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|